Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Neuropathol+Appl+Neurobiol 2021 ; 47 (1): 3-16 Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Invited Review: The spectrum of neuropathology in COVID-19 #MMPMID32935873
Al-Sarraj S; Troakes C; Hanley B; Osborn M; Richardson MP; Hotopf M; Bullmore E; Everall IP
Neuropathol Appl Neurobiol 2021[Feb]; 47 (1): 3-16 PMID32935873show ga
There is increasing evidence that patients with Coronavirus disease 19 (COVID-19) present with neurological and psychiatric symptoms. Anosmia, hypogeusia, headache, nausea and altered consciousness are commonly described, although there are emerging clinical reports of more serious and specific conditions such as acute cerebrovascular accident, encephalitis and demyelinating disease. Whether these presentations are directly due to viral invasion of the central nervous system (CNS) or caused by indirect mechanisms has yet to be established. Neuropathological examination of brain tissue at autopsy will be essential to establish the neuro-invasive potential of the SARS-CoV-2 virus but, to date, there have been few detailed studies. The pathological changes in the brain probably represent a combination of direct cytopathic effects mediated by SARS-CoV-2 replication or indirect effects due to respiratory failure, injurious cytokine reaction, reduced immune response and cerebrovascular accidents induced by viral infection. Further large-scale molecular and cellular investigations are warranted to clarify the neuropathological correlates of the neurological and psychiatric features seen clinically in COVID-19. In this review, we summarize the current reports of neuropathological examination in COVID-19 patients, in addition to our own experience, and discuss their contribution to the understanding of CNS involvement in this disease.
|COVID-19/*complications/*pathology[MESH]
|Female[MESH]
|Humans[MESH]
|Male[MESH]
|Nervous System Diseases/*pathology/*virology[MESH]
Neuropathol+Appl+Neurobiol 2021 ; 47 (1): 3-16
